Dr Blythe E Monheit, MD - Medicare Ophthalmology in Birmingham, AL

Dr Blythe E Monheit, MD is a medicare enrolled "Ophthalmology - Glaucoma Specialist" physician in Birmingham, Alabama. She went to University Of Alabama School Of Medicine and graduated in 2000 and has 24 years of diverse experience with area of expertise as Ophthalmology. She is a member of the group practice University Of Alabama Ophthalmology Services Foundation and her current practice location is 700 18th St S, Birmingham, Alabama. You can reach out to her office (for appointments etc.) via phone at (205) 325-8535.

Dr Blythe E Monheit is licensed to practice in Alabama (license number 24324) and she also participates in the medicare program. She accepts medicare assignments (which means she accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance) and her NPI Number is 1336196542.

Contact Information

Dr Blythe E Monheit, MD
700 18th St S,
Birmingham, AL 35233-1856
(205) 325-8535
(205) 325-8547



Physician's Profile

Full NameDr Blythe E Monheit
GenderFemale
SpecialityOphthalmology
Experience24 Years
Location700 18th St S, Birmingham, Alabama
Accepts Medicare AssignmentsYes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance.
  Medical Education and Training:
  • Dr Blythe E Monheit attended and graduated from University Of Alabama School Of Medicine in 2000
  NPI Data:
  • NPI Number: 1336196542
  • Provider Enumeration Date: 05/31/2006
  • Last Update Date: 11/23/2022
  Medicare PECOS Information:
  • PECOS PAC ID: 2163407339
  • Enrollment ID: I20040622000471

Medical Identifiers

Medical identifiers for Dr Blythe E Monheit such as npi, medicare ID, medicare PIN, medicaid, etc.
IdentifierTypeStateIssuer
1336196542NPI-NPPES
8AB071OtherTXBCBSTX
2119174-03MedicaidTX
2119174-02MedicaidTX
7827558OtherTXAETNA
P00348752OtherTXRAILROAD MEDICARE

Medical Taxonomies and Licenses

TaxonomyTypeLicense (State)Status
207W00000XOphthalmology 24324 (Alabama)Secondary
207WX0009XOphthalmology - Glaucoma Specialist 24324 (Alabama)Primary

Medical Facilities Affiliation

Facility NameLocationFacility Type
Callahan Eye HospitalBirmingham, ALHospital

Group Practice Association

Group Practice NameGroup PECOS PAC IDNo. of Members
University Of Alabama Ophthalmology Services Foundation923402341735

News Archive

Autism more common than previously thought

Just last week, U.S. health authorities announced that autism is more common than previously thought. About 1 in 88 children in the United States have an autism spectrum disorder, according to the report. Autism spectrum disorders are developmental conditions associated with impaired social communication and repetitive behaviors or fixated interests. Diagnoses have risen 78% since 2000, partly because of greater awareness, and partly for reasons entirely unknown. Most medications don't help, and while some find improvements with intense (and expensive) behavioral therapy, there is no cure.

Advanced Cell Diagnostics names Aquila-Histoplex as the first accredited RNAscope® Certified Service Provider in Europe

Aquila-Histoplex, a contract research organisation specialised in histological and multiplex staining technologies, was today announced as the first accredited RNAscope® Certified Service Provider in Europe by Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.

Study leads to discovery of rare genetic disorder

Recently, a grassroots effort initiated by families and clinicians led to the discovery of a human genetic disorder with severe consequences that is linked to a mutation in the human NGLY1 gene. In a big step towards understanding the effects of this mutation, research by scientists at the RIKEN-Max Planck Joint Research Center in Japan implicates the enzyme ENGase as the factor responsible for deficient protein degradation that occurs in the absence of mouse Ngly1 gene expression.

Seizures start with a hush: A spike in inhibition

Some patients describe epileptic seizures like an earthquake from within, starting slow and growing without their control. To a brain researcher, seizures are an electrical firestorm of neuronal activation in the brain.

Read more Medical News

› Verified 2 days ago

Medicare Reassignments

Some practitioners may not bill the customers directly but medicare billing happens through clinics / group practice / hospitals where the provider works. Medicare reassignment of benefits is a mechanism by which practitioners allow third parties to bill and receive payment for medicare services performed by them. Dr Blythe E Monheit allows following entities to bill medicare on her behalf.
Entity NameUniversity Of Alabama Ophthalmology Services Foundation
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1265485999
PECOS PAC ID: 9234023417
Enrollment ID: O20040210000034

News Archive

Autism more common than previously thought

Just last week, U.S. health authorities announced that autism is more common than previously thought. About 1 in 88 children in the United States have an autism spectrum disorder, according to the report. Autism spectrum disorders are developmental conditions associated with impaired social communication and repetitive behaviors or fixated interests. Diagnoses have risen 78% since 2000, partly because of greater awareness, and partly for reasons entirely unknown. Most medications don't help, and while some find improvements with intense (and expensive) behavioral therapy, there is no cure.

Advanced Cell Diagnostics names Aquila-Histoplex as the first accredited RNAscope® Certified Service Provider in Europe

Aquila-Histoplex, a contract research organisation specialised in histological and multiplex staining technologies, was today announced as the first accredited RNAscope® Certified Service Provider in Europe by Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.

Study leads to discovery of rare genetic disorder

Recently, a grassroots effort initiated by families and clinicians led to the discovery of a human genetic disorder with severe consequences that is linked to a mutation in the human NGLY1 gene. In a big step towards understanding the effects of this mutation, research by scientists at the RIKEN-Max Planck Joint Research Center in Japan implicates the enzyme ENGase as the factor responsible for deficient protein degradation that occurs in the absence of mouse Ngly1 gene expression.

Seizures start with a hush: A spike in inhibition

Some patients describe epileptic seizures like an earthquake from within, starting slow and growing without their control. To a brain researcher, seizures are an electrical firestorm of neuronal activation in the brain.

Read more Medical News

› Verified 2 days ago

Entity NameUab Callahan Eye Hospital Authority
Entity TypePart B Supplier - Clinic/group Practice
Entity IdentifiersNPI Number: 1023358850
PECOS PAC ID: 1557516895
Enrollment ID: O20130312000475

News Archive

Autism more common than previously thought

Just last week, U.S. health authorities announced that autism is more common than previously thought. About 1 in 88 children in the United States have an autism spectrum disorder, according to the report. Autism spectrum disorders are developmental conditions associated with impaired social communication and repetitive behaviors or fixated interests. Diagnoses have risen 78% since 2000, partly because of greater awareness, and partly for reasons entirely unknown. Most medications don't help, and while some find improvements with intense (and expensive) behavioral therapy, there is no cure.

Advanced Cell Diagnostics names Aquila-Histoplex as the first accredited RNAscope® Certified Service Provider in Europe

Aquila-Histoplex, a contract research organisation specialised in histological and multiplex staining technologies, was today announced as the first accredited RNAscope® Certified Service Provider in Europe by Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.

Study leads to discovery of rare genetic disorder

Recently, a grassroots effort initiated by families and clinicians led to the discovery of a human genetic disorder with severe consequences that is linked to a mutation in the human NGLY1 gene. In a big step towards understanding the effects of this mutation, research by scientists at the RIKEN-Max Planck Joint Research Center in Japan implicates the enzyme ENGase as the factor responsible for deficient protein degradation that occurs in the absence of mouse Ngly1 gene expression.

Seizures start with a hush: A spike in inhibition

Some patients describe epileptic seizures like an earthquake from within, starting slow and growing without their control. To a brain researcher, seizures are an electrical firestorm of neuronal activation in the brain.

Read more Medical News

› Verified 2 days ago

Medicare Part D Prescriber Enrollment

Any physician or other eligible professional who prescribes Part D drugs must either enroll in the Medicare program or opt out in order to prescribe drugs to their patients with Part D prescription drug benefit plans. Dr Blythe E Monheit is enrolled with medicare and thus, if eligible, can prescribe medicare part D drugs to patients with medicare part D benefits.

Mailing Address and Practice Location

Mailing AddressPractice Location Address
Dr Blythe E Monheit, MD
1720 University Blvd Ste 305,
Birmingham, AL 35233-1816

Ph: (205) 325-8535
Dr Blythe E Monheit, MD
700 18th St S,
Birmingham, AL 35233-1856

Ph: (205) 325-8535

News Archive

Autism more common than previously thought

Just last week, U.S. health authorities announced that autism is more common than previously thought. About 1 in 88 children in the United States have an autism spectrum disorder, according to the report. Autism spectrum disorders are developmental conditions associated with impaired social communication and repetitive behaviors or fixated interests. Diagnoses have risen 78% since 2000, partly because of greater awareness, and partly for reasons entirely unknown. Most medications don't help, and while some find improvements with intense (and expensive) behavioral therapy, there is no cure.

Advanced Cell Diagnostics names Aquila-Histoplex as the first accredited RNAscope® Certified Service Provider in Europe

Aquila-Histoplex, a contract research organisation specialised in histological and multiplex staining technologies, was today announced as the first accredited RNAscope® Certified Service Provider in Europe by Advanced Cell Diagnostics, Inc. (ACD), a technology and market leader in the field of molecular pathology and developer of cell and tissue-based analysis tools.

Study leads to discovery of rare genetic disorder

Recently, a grassroots effort initiated by families and clinicians led to the discovery of a human genetic disorder with severe consequences that is linked to a mutation in the human NGLY1 gene. In a big step towards understanding the effects of this mutation, research by scientists at the RIKEN-Max Planck Joint Research Center in Japan implicates the enzyme ENGase as the factor responsible for deficient protein degradation that occurs in the absence of mouse Ngly1 gene expression.

Seizures start with a hush: A spike in inhibition

Some patients describe epileptic seizures like an earthquake from within, starting slow and growing without their control. To a brain researcher, seizures are an electrical firestorm of neuronal activation in the brain.

Read more News

› Verified 2 days ago


Ophthalmology Doctors in Birmingham, AL

Carol E Rosenstiel, OD
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 700 18th St S Ste 200, Birmingham, AL 35233
Phone: 205-325-8620    
Alex J Wright, MD
Ophthalmology
Medicare: Medicare Enrolled
Practice Location: 1720 University Blvd, Birmingham, AL 35233
Phone: 205-325-8100    Fax: 205-325-8547
Elmar M Lawaczeck, M.D.
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 1009 Montgomery Hwy, Suite 200, Birmingham, AL 35216
Phone: 205-397-9400    Fax: 205-397-9455
Matthew Henry Oltmanns, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 2208 University Blvd Ste 101, Birmingham, AL 35233
Phone: 205-933-2625    Fax: 205-558-2553
Harold Augustus Helms, MD, PHD
Ophthalmology
Medicare: Not Enrolled in Medicare
Practice Location: 1100 23rd St S, Ste 100, Birmingham, AL 35205
Phone: 205-933-2020    Fax: 205-933-0908
Krupa Hasmukh Patel, M.D.
Ophthalmology
Medicare: Accepting Medicare Assignments
Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233
Phone: 205-325-8620    
William Charles Gambla, MD
Ophthalmology
Medicare: Medicare Enrolled
Practice Location: 700 18th St S Ste 601, Birmingham, AL 35233
Phone: 205-996-8660    

Find & Compare Providers Near You: Find and compare doctors, nursing homes, hospitals, and other health care providers in your area that accept Medicare. Get information like: Find a doctor or clinician that accepts Medicare near you.

Doctors and clinicians: Doctors and clinicians include doctors, clinicians and groups who are qualified to practice in many specialties. Each specialty focuses on certain parts of the body, periods of life, conditions, or primary care. The doctors, clinicians, and groups listed here typically work in an office or clinic setting. Also those who currently accept Medicare are included.

Hospitals: Find information about Medicare-certified hospitals and long-term care hospitals in your area, including Veterans Administration medical centers and military hospitals, across the country. Long-term care hospitals serve critically ill and medically complex patients who require extended hospital care.

Data provided: Information on www.medicareusa.org is built using open data sources published by Centers for Medicare & Medicaid Services (CMS) under Freedom of Information Act (FOIA).

© 2024 MedicareUsa. All rights reserved. Maintained by the Agency for Healthcare Research and Quality, U.S. Department of Health and Human Services.